Agenus Inc. (NASDAQ:AGEN) recovered 25.62% of its value since hitting low of $3.20. The recent move of 7.2% gain helped the stock to close at $4.02 when trading ended on 11/22/2017. At recent session, the prices were hovering between $3.725 and $4.05. This company shares are 173.63% off its target price of $11 and the current market capitalization stands at $350.7M. The recent change has given its price a -1.97% deficit over SMA 50 and -26.24% deficit over its 52-week high. The stock witnessed 7.77% gains, 8.36% gains and 14.86% gains for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found AGEN’s volatility during a week at 4.88% and during a month it has been found around 5.68%.Agenus Inc. (AGEN) Top Holders
Institutional investors currently hold around $142 million or 45.9% in AGEN stock. Look at its top three institutional owners. Blackrock Inc. owns $18.1 million in Agenus Inc., which represents roughly 5.16% of the company’s market cap and approximately 12.75% of the institutional ownership. Similar statistics are true for the second largest owner, Rtw Investments, Lp, which owns 4,218,520 shares of the stock are valued at $15.82 million. The third largest holder is Vanguard Group Inc, which currently holds $13.19 million worth of this stock and that ownership represents nearly 3.76% of its market capitalization.
At the end of September reporting period, 41 institutional holders increased their position in Agenus Inc. (NASDAQ:AGEN) by some 3,412,986 shares, 40 decreased positions by 4,816,815 and 36 held positions by 29,716,134. That puts total institutional holdings at 37,945,935 shares, according to SEC filings. The stock grabbed 10 new institutional investments totaling 967,891 shares while 15 institutional investors sold out their entire positions totaling 2,046,715 shares.Agenus Inc. (NASDAQ:AGEN) Insider Trades
Multiple company employees have indulged in significant insider trading. Agenus Inc. disclosed in a document filed with the US Securities and Exchange Commission (SEC) that Chairman & CEO Armen Garo H has acquired 100,000 shares of Agenus Inc. (AGEN) in trading session dated Oct. 30, 2017. These shares are worth $355,000 and were traded at $3.55 each. The SEC filing shows that Armen Garo H performed a purchase of 100,000 shares. The Chairman & CEO added these shares by way of transaction on Apr. 12, 2017. The company’s shares were assimilated at $3.35 per share worth to an investment of some $335,000 on account of Armen Garo H.
10% Owner, Incyte Corp, purchased 10,000,000 common shares of Agenus Inc. (AGEN) in the open market. In a transaction dated Feb. 14, 2017, the shares were bought at an average price of $6, giving away a sum of $60,000,000. After this purchase, 17,763,968 common shares of AGEN are directly owned by the insider, with total stake valued at $71,411,151.
In the transaction dated Sep. 06, 2016, the great number of shares acquired came courtesy the Director; Wiinberg Ulf added a total of 30,000 shares at an average price of $6.29, amounting to approximately $188,700. The insider now directly owns 30,000 shares worth $120,600.Agenus Inc. (AGEN) Analyst Guide
Not many analysts have released their opinion on Agenus Inc. (NASDAQ:AGEN), with 1 analysts believing it is a strong buy. Whereas 0 of them predict the stock is a hold. Also, there are 0 buy, 0 sell and 0 strong sell ratings, collectively assigning a 1 average brokerage recommendation.